Posts by: Magdalena Kegel

Magdalena Kegel

Magdalena holds an MSc in Pharmaceutical Bioscience and an interdisciplinary PhD merging the fields of psychiatry, immunology and neuropharmacology. Her previous research focused on metabolic and immunologic changes in psychotic disorders. She is now focusing on science writing, allowing her to culture her passion for medical science and human health.

April 18, 2016April 18, 2016

Depression in Crohn’s Disease Patients Linked in Study to Disease Flares and Hospitalizations

Crohn's Disease, IBD News, News

Crohn’s disease patients who suffer from depression are at an increased risk for exacerbation of their symptoms and hospitalization, according to a study in The American Journal of Gastroenterology. The ... Read more

March 10, 2016March 10, 2016

Use of Glutamine in Crohn’s Disease Needs More Evaluation, Review Finds

News

A review published by the The Cochrane Library reported that there is not enough evidence to draw conclusions about the efficacy and safety of glutamine for inducing remission in patients with Crohn’s ... Read more

March 4, 2016March 4, 2016

Patients with Crohn’s and Ulcerative Colitis Show Promising Results in Entyvio Clinical Trials

News

Recently compiled safety data from all clinical trials on Entyvio (vedolizumab) for patients with inflammatory bowel disease (IBD) show the drug is associated with low rates of new serious infections, infusion-related reactions, and cancers. ... Read more

March 2, 2016March 2, 2016

Gut Microbiome in IBD Patients Responds Differently to Iron Supplements Given Oral and Intravenously

Crohn's Disease, IBD News, News, Ulcerative colitis

Researchers from the Technical University of Munich, Germany, found that iron supplementation in patients with inflammatory bowel disease (IBD) affects the gut microbiome differently, depending on the route of administration. Intravenous ... Read more

February 17, 2016February 17, 2016

Children with Ulcerative Colitis May Be Safely Treated with Multimatrix Mesalamine

IBD News, News, Ulcerative colitis

A study from the Johns Hopkins University School of Medicine reported that children and adolescents with ulcerative colitis (UC) reacted to multimatrix mesalamine treatment in ways similar to adults, with the ... Read more

February 16, 2016February 16, 2016

Ulcerative Colitis Patients Resistant to Treatment May Find Golimumab a Viable Therapeutic Option

IBD News, News, Ulcerative colitis

Golimumab (symponi) is the latest addition to TNF-α blocking drugs for inflammatory bowel diseases (IBD) such as ulcerative colitis (UC). A summary of all available safety and efficacy data on the ... Read more

February 11, 2016February 12, 2016

RedHill Biopharma’s Potential Crohn’s Treatment, RHB-104, Likely to Receive US Patent

Crohn's Disease, IBD News, News

RedHill Biopharma recently announced that it received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for its patent covering RHB-104, a new oral combination drug currently being assessed in clinical ... Read more

February 9, 2016February 9, 2016

In IBD Colon Inflammation in Children, Immune Factor Identified as Driving the Disease

News

A research team at Our Lady’s Children’s Hospital Crumlin (OLCHC) in collaboration with the Trinity College, Ireland, found that the cytokine interleukin-36 (IL-36) is present in higher levels in the colon ... Read more

January 25, 2016January 25, 2016

IBD Inflammation May Be Reduced With Omega-3 Fatty Acids

News

Omega-3 fatty acids might prevent or reduce symptoms of inflammatory bowel disease (IBD) by decreasing inflammation. A review found that while not all studies agree, research points to the possibility ... Read more

January 5, 2016January 5, 2016

Inflammatory Genes Increase Risk of IBD

News, Ulcerative colitis

A new Danish study investigating the genetics behind inflammatory bowel disease (IBD) found that variants of inflammatory genes TLR1 and IL12B are associated with an increased risk of developing the disease. The ... Read more